- Home
- GASS vs ESPR Comparison
GASS vs ESPR Comparison
Compare GASS & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GASS
- ESPR
- Stock Information
- Founded
- GASS 2004
- ESPR 2008
- Country
- GASS Greece
- ESPR United States
- Employees
- GASS N/A
- ESPR N/A
- Industry
- GASS Marine Transportation
- ESPR Biotechnology: Pharmaceutical Preparations
- Sector
- GASS Consumer Discretionary
- ESPR Health Care
- Exchange
- GASS Nasdaq
- ESPR Nasdaq
- Market Cap
- GASS 224.5M
- ESPR 208.1M
- IPO Year
- GASS 2005
- ESPR 2013
- Fundamental
- Price
- GASS $6.44
- ESPR $1.18
- Analyst Decision
- GASS
- ESPR Buy
- Analyst Count
- GASS 0
- ESPR 6
- Target Price
- GASS N/A
- ESPR $6.50
- AVG Volume (30 Days)
- GASS 103.8K
- ESPR 3.2M
- Earning Date
- GASS 05-28-2025
- ESPR 08-11-2025
- Dividend Yield
- GASS N/A
- ESPR N/A
- EPS Growth
- GASS 27.26
- ESPR N/A
- EPS
- GASS 1.80
- ESPR N/A
- Revenue
- GASS $167,724,264.00
- ESPR $259,574,000.00
- Revenue This Year
- GASS $2.94
- ESPR $4.07
- Revenue Next Year
- GASS $3.49
- ESPR N/A
- P/E Ratio
- GASS $3.59
- ESPR N/A
- Revenue Growth
- GASS 14.07
- ESPR 12.99
- 52 Week Low
- GASS $4.82
- ESPR $0.69
- 52 Week High
- GASS $7.68
- ESPR $3.94
- Technical
- Relative Strength Index (RSI)
- GASS 53.17
- ESPR 61.39
- Support Level
- GASS $6.27
- ESPR $0.95
- Resistance Level
- GASS $6.66
- ESPR $1.06
- Average True Range (ATR)
- GASS 0.25
- ESPR 0.08
- MACD
- GASS -0.06
- ESPR -0.00
- Stochastic Oscillator
- GASS 19.10
- ESPR 83.33
About GASS StealthGas Inc.
StealthGas Inc is an international shipping transportation company. It owns liquefied petroleum gas (LPG) pressurized carriers and provides international seaborne transportation services to LPG producers and users, as well as crude oil and product carriers to oil producers, refineries, and commodities traders. The company carriers carry various petroleum gas products in liquefied forms, such as propane, butane, butadiene, isopropane, propylene, and vinyl chloride monomer, which are all byproducts of the production of crude oil and natural gas.
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.